Angiogenesis
From Kidney Cancer Resource
Contents |
Overview
Detail
Angiogenesis (angio- blood vessel; genesis—creation) is the process of creating new blood vessels, mainly small ones called capillaries. These are tiny vessels of microscopic diameter and a thin wall of one cell width. But despite, or maybe because, of their diminutive size, capillaries are of enormous importance—they deliver the oxygen and nutrients from blood to tissue. Without them—no oxygen, no nutrients, no life.
Now here is the hooker: they supply tumor tissue just as well as they supply normal tissue. In fact, tumors secrete several proteins in an attempt attract new vessels toward them, chief among them is Vascular Endothelial Growth Factor, or VEGF.
Here comes Judah
Dr. Folkman made an astute observation. When he implanted tumor cells under the skin of mice, they started dividing as expected. But then, when the tumor reached a volume of about 1 mm³, growth stopped in its tracks. And there the tumor sat—no growth. But after a while, new blood vessels started growing toward the tumor, growth took off again and even metastasized to new locations. So the logic was simple: inhibit the growth of blood vessels, and you inhibit the growth and spread of tumors. The reasons for skepticism and criticism were myriad: “everybody knows” that tumors don’t need blood supply, and how do you inhibit the “bad” blood vessels without affecting the normal ones? And so on, and so on. In fact, the critics, some of them serving on NIH grant review committees—tried to choke off his research by rejecting his grant application. Poor science, naїve, undocumented claims; these were some of the choice reasons for rejection.
Judah was undeterred by the criticisms and rejections. He received support from industry (for which he was roundly criticized by, among others, the same people who had denied him NIH support), and proceeded to do the experiments. In the end, the facts spoke for themselves, and loudly. His theory about tumor dependence of blood supply proved correct. And as common in science, his discoveries led to further discoveries: the factors that attract blood vessels toward the tumor were identified. Other factors secreted by the tumors were shown to inhibit angiogenesis, and it became clear that it is the balance between the Ying and the Yang that determines the degree of tumor angiogenesis. Judah identifies two proteins that were inhibitory of angiogenesis. These were the proteins that caused the little baby’s miraculous cure. Genentech created an antibody molecule that inhibited VEGF. The drug, called Avastin, is now a mainstay of therapy of colon cancer, lung cancer, kidney cancer, breast cancer, and the list is getting longer every time I check. Even macular degeneration is treated with anti-VEGF. Over 20 other anti-angiogenic drugs are in various stages of development.
Articles
Sydney Morning Herald (KC) 17-Apr-08
|
Disclaimer
Kidney Cancer Resource (KCR) is not influenced by sponsors. The information contained herein is not intended as a substitute for the advice of an appropriately qualified and licensed physician or other licensed health care provider. The information provided here is for educational and information purposes only. Early accurate Diagnosis (Dx.) saves lives. Please check with a physician if you suspect you are ill, never ignore Symptoms. To help your health care specialist make an accurate Diagnosis please keep notes of dates, times and details of your Symptoms. We are not offering medical advice nor do we consider links, individuals or articles accessed through this site to be offering medical advice.
E&OE - Errors & Omissions Excepted
As much of the information posted on this Web Site for peoples convenience is of a medical or technical nature, and may be a matter of life or death the E&OE is a Disclaimer showing that to the best of our ability information is accurate and correctly written or transcribed. Before acting on information on this site you are responsible for checking it with your relevant medical team. We can not be held responsible for any Errors & Omissions made; nor for information on links and articles provided in good faith.